Bestzyme launches world’s first automated smart production line for sweet proteins in Jinan, marking a milestone for alternative sweetener manufacturing
Executive summary: Bestzyme completed the world’s first dedicated automated smart production line for sweet proteins at its Jinan plant on September 21, 2026. The line enables scalable, low‑cost production of high‑intensity sweet proteins, offering an alternative to traditional sugars and potentially reducing production costs for food‑and‑beverage manufacturers.
Who is involved: Bestzyme (a unit of GenScript Biotech), located in Jinan, China, carried out the launch; the announcement was distributed via PR Newswire.
Likely next: The company is expected to seek regulatory approval for the sweet proteins as a novel food ingredient and begin commercial sales to food‑and‑beverage customers.
On September 21, 2026, Bestzyme, a synthetic biology subsidiary of GenScript Biotech, announced completion of a dedicated automated smart production line for sweet proteins at its Jinan facility. The line is described as the world’s first fully automated system for manufacturing sweet proteins, which are low‑calorie, high‑intensity sweeteners derived from recombinant sources. The development underscores the company’s push to scale novel food‑ingredient technologies and could influence the supply chain for sugar‑reduction products.
What's next — scenarios
Commercial Cost Parity & Scale (50%)
Food and beverage brands will accelerate reformulation of low-calorie products, putting margin pressure on traditional high-intensity artificial sweeteners.
- Announcement of major multinational beverage contracts using Bestzyme's sweet proteins
- Public disclosure of production cost benchmarks dropping below traditional alternatives
Regulatory and Scaling Friction (30%)
Global expansion will stall, forcing Bestzyme to rely primarily on the domestic Chinese market and delaying broader supply chain disruption.
- Delays in FDA or EFSA novel food approvals for recombinant sweet proteins
- Technical yield bottlenecks reported at the Jinan facility
Aggressive Competitor Fast-Following (20%)
Rival synthetic biology firms will rapidly announce competing automated lines, triggering a price war and compressing supplier margins early.
- Competitors announce similar automated synthetic biology production facilities within 60 days
- Significant patent litigation or IP challenges filed against Bestzyme's production tech
What to watch
- Global regulatory filings for sweet proteins by Bestzyme in the US (FDA) or Europe (EFSA) over the next 90 days
- Quarterly financial disclosures from GenScript Biotech regarding Jinan facility utilization rates by Q1 2027
- Announcements of commercial supply partnerships between Bestzyme and tier-1 global F&B companies within the next 60 days
Timeline
- — Bestzyme Launches World's First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan (PR Newswire)
Analysis — what this means
Sectors affected
- alternative sweeteners industry
- food ingredient manufacturing
- synthetic biology food‑tech